The collaboration addresses delays in diagnosis and treatment by leveraging AI to help ensure patients with prostate and breast cancer are identified and treated more promptly.
Immersive technologies offer powerful new tools for mental healthcare, but their implementation must be grounded in clinical principles and executed with competence.
The company will use the funds to grow its team, expedite commercial deployments with pharma companies and enhance Willis, its new clinical outcome assessment platform.